The Time Is Now:
Understanding Gene Therapy, Applications, and Implications
Brought to you by:
Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC working in collaboration with the National Organization for Rare Disorders (NORD).
This 4-session CME/CE series is designed to help healthcare providers recognize which gene therapies are available to treat which diseases, understand the rationale for each gene-therapy approach, and identify, inform, and refer the correct patients for counseling and treatment. Gene therapy has the potential to revolutionize care for a broad range of medical conditions, offering treatment with durable response for many diseases considered “untreatable” or only manageable with supportive-care, minimally effective, or toxic options. With the gene-therapy landscape evolving rapidly and hundreds of agents in various stages of investigation, it can be challenging for clinicians to identify appropriate patient candidates and ensure they have access to these breakthrough treatments.